Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
1.720
+0.070 (4.24%)
At close: Aug 13, 2025, 4:00 PM
1.730
+0.010 (0.58%)
Pre-market: Aug 14, 2025, 9:17 AM EDT
Biomea Fusion Market Cap
Biomea Fusion has a market cap or net worth of $102.35 million as of August 14, 2025. Its market cap has decreased by -48.04% in one year.
Market Cap
102.35M
Enterprise Value
53.18M
1-Year Change
-48.04%
Ranking
Category
Stock Price
$1.72
Market Cap Chart
Since the IPO on April 16, 2021, Biomea Fusion's market cap has decreased from $489.05M to $102.35M, a decrease of -79.07%. That is a compound annual growth rate of -30.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 102.35M | -27.20% |
| Dec 31, 2024 | 140.61M | -72.88% |
| Dec 29, 2023 | 518.45M | 109.21% |
| Dec 30, 2022 | 247.81M | 14.52% |
| Dec 31, 2021 | 216.38M | -55.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |